Medcomtech, S.A.

BME:MED Stock Report

Market Cap: €8.9m

Medcomtech Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Medcomtech.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth24.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Returns Are Gaining Momentum At Medcomtech (BME:MED)

Oct 18
Returns Are Gaining Momentum At Medcomtech (BME:MED)

Many Still Looking Away From Medcomtech, S.A. (BME:MED)

Aug 26
Many Still Looking Away From Medcomtech, S.A. (BME:MED)

Returns At Medcomtech (BME:MED) Are On The Way Up

Mar 21
Returns At Medcomtech (BME:MED) Are On The Way Up

Medcomtech (BME:MED) Is Experiencing Growth In Returns On Capital

Dec 06
Medcomtech (BME:MED) Is Experiencing Growth In Returns On Capital

Investors Will Want Medcomtech's (BME:MED) Growth In ROCE To Persist

Aug 16
Investors Will Want Medcomtech's (BME:MED) Growth In ROCE To Persist

Medcomtech (BME:MED) Is Looking To Continue Growing Its Returns On Capital

Apr 09
Medcomtech (BME:MED) Is Looking To Continue Growing Its Returns On Capital

Here's Why Medcomtech (BME:MED) Can Afford Some Debt

May 17
Here's Why Medcomtech (BME:MED) Can Afford Some Debt

Should Weakness in Medcomtech, S.A.'s (BME:MED) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Nov 30
Should Weakness in Medcomtech, S.A.'s (BME:MED) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medcomtech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

BME:MED - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202327-1-4-2N/A
3/31/202326-2-3-2N/A
12/31/202225-2-3-2N/A
9/30/202224-1-3-2N/A
6/30/202224-1-4-2N/A
3/31/202223-1-3-1N/A
12/31/202123-1-20N/A
9/30/202122-1-20N/A
6/30/202122-1-20N/A
3/31/202120-2-20N/A
12/31/202019-2-2-1N/A
9/30/202019-4-2-1N/A
6/30/202019-6-1-1N/A
3/31/202021-1-2-2N/A
12/31/2019224-3-2N/A
9/30/2019224-3-2N/A
6/30/2019224-2-1N/A
3/31/201923-201N/A
12/31/201824-823N/A
9/30/201826-834N/A
6/30/201828-755N/A
3/31/201828-533N/A
12/31/201729-312N/A
12/31/201628-3N/A1N/A
12/31/201525-1N/A-2N/A
6/30/2015220N/A2N/A
3/31/2015211N/A1N/A
12/31/2014201N/A1N/A
9/30/2014201N/AN/AN/A
6/30/2014191N/A0N/A
3/31/2014191N/A1N/A
12/31/2013181N/A3N/A
9/30/2013181N/AN/AN/A
6/30/2013171N/A1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if MED's forecast earnings growth is above the savings rate (1.4%).

Earnings vs Market: Insufficient data to determine if MED's earnings are forecast to grow faster than the Spanish market

High Growth Earnings: Insufficient data to determine if MED's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if MED's revenue is forecast to grow faster than the Spanish market.

High Growth Revenue: Insufficient data to determine if MED's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MED's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/04/13 07:48
End of Day Share Price 2024/01/15 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medcomtech, S.A. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael Thomas CooperEdison Investment Research
Natalia BjorkKepler Capital Markets